Publicaciones en las que colabora con RAFAEL BALAÑA FOUCE (26)

2024

  1. Free Radical Production Induced by Nitroimidazole Compounds Lead to Cell Death in Leishmania infantum Amastigotes

    Molecules, Vol. 29, Núm. 17

  2. In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against Leishmania

    Tropical Medicine and Infectious Disease, Vol. 9, Núm. 2

  3. Polyamine Metabolism for Drug Intervention in Trypanosomatids

    Pathogens, Vol. 13, Núm. 1

  4. Targeting Trypanothione Metabolism in Trypanosomatids

    Molecules, Vol. 29, Núm. 10

2023

  1. Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates

    Biomolecules, Vol. 13, Núm. 4

  2. Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains

    PLoS neglected tropical diseases, Vol. 16, Núm. 2, pp. e0010170

  2. Characterization of the gene encoding s‐adenosyl‐l‐methionine (Adomet) synthetase in penicillium chrysogenum; role in secondary metabolism and penicillin production

    Microorganisms, Vol. 10, Núm. 1

2021

  1. Reproduction in trypanosomatids: Past and present

    Biology, Vol. 10, Núm. 6

2020

  1. Screening marine natural products for new drug leads against trypanosomatids and malaria

    Marine Drugs, Vol. 18, Núm. 4

2019

  1. Current and promising novel drug candidates against visceral leishmaniasis

    Pure and Applied Chemistry

  2. DNA topoisomerases of leishmania parasites; druggable targets for drug discovery

    Current Medicinal Chemistry, Vol. 26, Núm. 32, pp. 5900-5923

  3. Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 11, pp. 39-48

2016

  1. Current status on prevention and treatment of canine leishmaniasis

    Veterinary Parasitology, Vol. 227, pp. 98-114

2014

  1. Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 4, Núm. 3, pp. 326-337

2011

  1. Leishmania donovani: Proteasome-mediated down-regulation of methionine adenosyltransferase

    Parasitology, Vol. 138, Núm. 9, pp. 1082-1092

2010

  1. DNA topoisomerases in apicomplexan parasites: Promising targets for drug discovery

    Proceedings of the Royal Society B: Biological Sciences

2008

  1. Characterization of the 5′ region of the Leishmania infantum LORIEN/MAT2 gene cluster and role of LORIEN flanking regions in post-transcriptional regulation

    Biochimie, Vol. 90, Núm. 9, pp. 1325-1336

  2. Gene disruption of the DNA topoisomerase IB small subunit induces a non-viable phenotype in the hemoflagellate Leishmania major

    BMC Microbiology, Vol. 8

2007

  1. Analysis of genetic elements regulating the methionine adenosyltransferase gene in Leishmania infantum

    Gene, Vol. 389, Núm. 2, pp. 163-173